US Human Proteome Organization (HUPO) 15th Annual Conference, March 3-6, 2019, Rockville, MD Quantitative Protein Expression Biomarker Feasibility in Advanced Ovarian Cancer, Morand S, Ngo N, Stanberry L, Egan C, Kaur P, Asea A, Nemunaitis J
Yeah, you got your defense
To extend its half-life through reversible albumin binding
Sn phm cn c kh nng o thi c t ra khi c th, tng cng kh nng min dch, bo v c th trc tc ng t mi trng
FDA in 2002, for the symptomatic treatment of BPH after significant serum DHT suppression (94.7%3.3% ) in Phase II, double-blind, placebo controlled, comparative dose-ranging trial, greater than with finasteride (70.818.3%, p 90% by forming a stable complex with a slow rate of dissociation constant [39]
Travlos G